WILMINGTON, DE, Truveris, the leader in pharmacy cost containment and program performance, today announced it has raised $15 million in Series E investment.
Truveris today announced it has raised $15 million in Series E investment led by two lead investors, Canaan Partners and New Leaf Venture Partners.
Truveris is a leading healthcare technology company focused on transforming and reducing pharmacy spend. Truveris has built the only independent, data-led, tech platform that creates complete PBM pricing transparency and drives competition to reduce costs for employers. Our solutions replace traditional pharmacy procurement and renewal models for self-insured employers by providing deep insights, comparative procurement, 100% claims analysis, and member engagement solutions.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.